Cellwise(SH:688325)2023-10-27 16:00Financial Performance - The company's operating revenue for Q3 2023 was ¥66,430,334.19, representing an increase of 86.05% compared to the same period last year[5]. - The net profit attributable to shareholders for Q3 2023 was ¥14,571,018.88, with a year-to-date net profit of ¥19,111,147.33, reflecting a decrease of 25.36% year-on-year[5]. - The net profit after deducting non-recurring gains and losses for Q3 2023 was ¥6,141,450.12, with a significant decline of 95.92% year-to-date[5]. - Basic earnings per share for Q3 2023 were ¥0.1754, down 35.33% compared to the previous year[6]. - Total operating revenue for the first three quarters of 2023 reached ¥151,059,459.89, an increase of 4.8% compared to ¥144,681,157.92 in the same period of 2022[20]. - Net profit for the third quarter of 2023 was ¥19,111,147.33, a decrease of 25.4% from ¥25,606,047.13 in the same quarter of 2022[21]. - The total comprehensive income for the third quarter of 2023 was CNY 19,098,381.37, a decrease of 25.3% compared to CNY 25,551,572.13 in the same period of 2022[22]. - Basic earnings per share for Q3 2023 was CNY 0.23, down from CNY 0.36 in Q3 2022, representing a decline of 36.1%[22]. Research and Development - The total R&D investment for Q3 2023 was ¥21,979,289.20, accounting for 33.09% of operating revenue, a decrease of 16.56 percentage points year-on-year[6]. - The decline in net profit was primarily due to a decrease in gross margin and an increase in R&D expenses[11]. - Research and development expenses for the first three quarters of 2023 amounted to ¥60,690,120.02, compared to ¥50,064,412.33 in 2022, indicating a growth of 21.2%[20]. Assets and Liabilities - The company's total assets at the end of Q3 2023 were ¥1,722,590,851.04, an increase of 1.28% from the end of the previous year[6]. - Total liabilities increased to ¥65,405,566.53 in the third quarter of 2023, compared to ¥54,925,806.56 in the same period of 2022, marking a rise of 19.5%[18]. - The company's total equity reached ¥1,657,185,284.51, an increase from ¥1,645,894,443.88 in the previous year[18]. - The company's cash and cash equivalents decreased to ¥769,320,924.33 from ¥1,603,294,805.61, a decline of 52.0%[18]. - The company's total assets as of the end of the third quarter of 2023 were ¥1,722,590,851.04, slightly up from ¥1,700,820,250.44 at the end of 2022[18]. Cash Flow - The cash flow from operating activities for the year-to-date was ¥25,453,624.36[6]. - Net cash flow from operating activities for the first three quarters of 2023 was CNY 25,453,624.36, a significant improvement from a negative CNY 18,159,910.67 in the same period of 2022[25]. - Cash inflow from investment activities in the first three quarters of 2023 was CNY 2,133,871,174.27, compared to CNY 482,436,997.73 in the same period of 2022, indicating a substantial increase[25]. - The net cash flow from financing activities for Q3 2023 was negative CNY 11,301,343.60, contrasting sharply with a positive CNY 1,356,772,871.12 in Q3 2022[26]. Shareholder Information - The total number of common shareholders at the end of the reporting period was 9,132, with no preferred shareholders reported[14]. - The top ten shareholders held a combined total of 21.1% of the shares, with the largest shareholder holding 11.7%[14]. Future Outlook - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[19]. - The company has not provided specific future guidance or market expansion strategies in the latest earnings call[15]. Other Information - The company has not disclosed any new product developments or technological advancements during the reporting period[15]. - There are no significant mergers or acquisitions reported in the current quarter[15]. - The company has adopted new accounting standards starting in 2023, which may impact the financial reporting and asset recognition[28].